Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome

OBJECTIVES: To evaluate whether risk scores used to classify patients with primary myelofibrosis and JAK-2 V617F mutation status can predict clinical outcome. METHODS: A review of clinical and laboratory data from 74 patients with primary myelofibrosis diagnosed between 1992 and 2011. The IPSS and L...

Descripción completa

Detalles Bibliográficos
Autores principales: Benites, Bruno Deltreggia, Lima, Carolina Silva Costa, Lorand-Metze, Irene, Delamain, Marcia Torresan, Oliveira, Gislaine Borba, de Almeida, Daiane, de Souza, Carmino Antonio, Vassallo, Jose, Pagnano, Katia Borgia Barbosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611898/
https://www.ncbi.nlm.nih.gov/pubmed/23644853
http://dx.doi.org/10.6061/clinics/2013(03)OA09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611898/
https://www.ncbi.nlm.nih.gov/pubmed/23644853
http://dx.doi.org/10.6061/clinics/2013(03)OA09

Ejemplares similares